image
Healthcare - Biotechnology - NASDAQ - US
$ 0.5
-9.26 %
$ 6.21 M
Market Cap
-0.3
P/E
BALANCE SHEET
14.5 M ASSETS
47.05%
6.36 M LIABILITIES
1.95%
8.39 M EQUITY
170.71%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ABVC BioPharma, Inc.
image
Current Assets 1.66 M
Cash & Short-Term Investments 139 K
Receivables 760 K
Other Current Assets 758 K
Non-Current Assets 12.8 M
Long-Term Investments 2.53 M
PP&E 8.78 M
Other Non-Current Assets 1.53 M
Current Liabilities 5.93 M
Accounts Payable 0
Short-Term Debt 1.87 M
Other Current Liabilities 4.06 M
Non-Current Liabilities 429 K
Long-Term Debt 407 K
Other Non-Current Liabilities 21.7 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Dec-2011 Sep-2010 Sep-2009 Sep-2008 Sep-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
ASSETS
Cash & Cash Equivalents 60.2 K 85.3 K 5.8 4.3 0.1 40 K 0.3 0.2 3.36 K 0 618 13.4 K 71.8 K 2.81 K 0 1.0 0.8 87.8 K 63.4 K 81.8 K 0.1 0
Short Term Investments 79.3 K 75.8 K 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.8 1.4 1.7 1.0 0.6 14.6 K 0 0 0 0 1.24 K 0 0 0 0 0 1.12 K 317 0 0 0 0
Inventory 0 1.3 26 K (0.8) (0.5) 1.32 K 0.2 0 274 795 0 0 0 0 0 0 0 0 0 8.48 K 6.36 K 40 K
Other Current Assets 0.8 1.5 1.9 0.9 93.4 K 40.3 K 2.5 0 3.82 K 0 0 35 K 30.1 K 30.3 K 1.4 K 25.2 K 70.9 K 175 0 0 0 0
Total Current Assets 1.7 3.0 9.6 6.2 0.9 96.3 K 0.8 0.2 3.63 K 0 1.86 K 48.3 K 0.1 33.2 K 1.4 K 1.0 0.9 88.3 K 63.4 K 90.3 K 0.1 40 K
PP&E 8.8 1.7 2.0 2.3 1.0 0.5 0.6 0 0 0 37.2 K 46.8 K 59.7 K 41.9 K 66.7 K 76.2 K 17.9 K 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 64.6 K 64.6 K 0.2 0.2 0.2 0.2 0.5 0.4 0.3 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 2.5 3.7 0.9 1.2 3.4 3.5 4.2 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.5 1.3 0.2 0.2 0.2 27.4 K (5.8) 3.82 K (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 (5.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 14.5 9.9 13.7 11.6 6.9 96.3 K 6.6 0.2 68.2 K 64.6 K 0.2 0.3 0.4 0.3 0.5 1.5 1.2 88.3 K 63.4 K 90.3 K 0.1 40 K
LIABILITIES
Accounts Payable 0 0 0 23 K 24 K 0 0 18.4 K 0 0 0.2 80.8 K 27.9 K 1.2 1.3 1.4 0.4 3.07 K 2.72 K 2.96 K 10.4 K 0
Short Term Debt 1.9 2.3 2.0 2.4 4.3 0.6 1.1 0 46.6 K 7 K 1.8 1.1 1.2 1.4 0.8 1.1 0.4 0 0 0 4.54 K 30 K
Other Current Liabilities 3.9 3.3 1.7 2.4 2.9 5.0 3.3 6.5 0.3 27 K (1.9) 0.7 0.7 0.6 0.4 0.2 29.8 K 50 K 0 0 11.3 K 0
Total Current Liabilities 5.9 5.8 3.7 4.8 6.8 5.6 4.1 56.5 K 39.2 K 34 K 2.1 1.9 1.8 3.3 2.5 2.7 0.9 53.1 K 2.72 K 2.96 K 26.3 K 30 K
Long Term Debt 0.4 0.8 1.1 4.1 0.2 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 21.7 K 7.98 K 10.6 K 19.3 K 2.88 K 27.5 K 0 0 0 0 1.3 0 1 0 0 0 0 0 0 0 0 30 K
Total Liabilities 6.4 6.2 4.8 8.9 7.1 5.8 4.1 56.5 K 39.2 K 34 K 2.1 1.9 1.8 3.3 2.5 2.7 0.9 53.1 K 2.72 K 2.96 K 26.3 K 30 K
EQUITY
Common Stock 7.94 K 32.9 K 28.9 K 24.4 K 19.5 K 0.2 4.12 K 0.2 60 K 54.6 K 54.6 K 54.6 K 14.2 K 32.9 K 32.9 K 32.2 K 32.2 K 1.02 K 1.02 K 1.02 K 1.02 K 0
Retained Earnings (65.4) (54.9) (38.5) (25.6) (15.9) (19.9) (10.0) (4.8) 55.5 K 24 K (30.6) (30.3) (28.8) (25.8) (22.7) (14.9) (5.9) 97.1 K 71.7 K 45 K 47.5 K 20 K
Other Accumulative Comprehensive Income/Loss 0.5 0.5 0.5 0.6 0.7 1.0 0.8 0 (0.3) 0 0 0 0 70 K 50 K 20 K 0 0 0 0 0 0
Total Equity 8.1 3.6 8.9 2.7 (0.1) (5.4) 2.5 0.1 29.1 K 30.6 K (1.9) (1.6) (1.5) (3.0) (2.0) (1.2) 0.3 35.3 K 60.7 K 87.3 K 84.8 K 10 K
Total Liabilities and Equity 14.5 9.9 13.7 11.6 6.9 96.3 K 6.6 0.2 68.2 K 64.6 K 0.2 0.3 0.4 0.3 0.5 1.5 1.2 88.3 K 63.4 K 90.3 K 0.1 40 K
SHARES OUTSTANDING
Common Shares Outstanding 4.3 3.2 2.5 2.0 1.7 1.2 0.2 1.1 87.3 K 190 190 190 49 22 22 2.03 K 3.66 K 3.66 K 3.66 K 3.66 K 22 28.6